INTERNATIONAL PATENT: TERNS PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT OF LIVER DISORDERS WITH A THR-BETA AGONIST"

GENEVA, Dec. 2 -- TERNS PHARMACEUTICALS, INC. (1065 E Hillsdale Blvd., Suite 100Foster City, California 94404) filed a patent application (PCT/US2025/030358) for "TREATMENT OF LIVER DISORDERS WITH A THR-BETA AGONIST" on May 21, 2025. With publication no. WO/2025/245216, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KURIAKOSE, Emil T. (c/o Terns Pharmaceuticals, Inc.1065 E Hillsdale Blvd., Suite 100Foster City, California 94404), JONES, Christopher T. (c/o Terns Pharmaceuticals, Inc.1065 E Hillsdale Blvd., Suite 100Foste...